Ruben Baumgarten Selected Research

Nephrogenic Diabetes Insipidus

1/2021	Genetic background determines renal response to chronic lithium treatment in female mice.
12/2019	Identification of Acer2 as a First Susceptibility Gene for Lithium-Induced Nephrogenic Diabetes Insipidus in Mice.
1/2018	Lithium induces aerobic glycolysis and glutaminolysis in collecting duct principal cells.
1/2017	Lithium-induced NDI: acetazolamide reduces polyuria but does not improve urine concentrating ability.
7/2016	Acetazolamide Attenuates Lithium-Induced Nephrogenic Diabetes Insipidus.
6/2016	Lithium in the Kidney: Friend and Foe?
3/2014	Lithium causes G2 arrest of renal principal cells.
3/2014	Hydrochlorothiazide attenuates lithium-induced nephrogenic diabetes insipidus independently of the sodium-chloride cotransporter.
7/2007	Urine osmolality, cyclic AMP and aquaporin-2 in urine of patients under lithium treatment in response to water loading followed by vasopressin administration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ruben Baumgarten Research Topics

Disease

9	Nephrogenic Diabetes Insipidus 01/2021 - 07/2007
5	Bipolar Disorder (Manic Depressive Psychosis) 12/2019 - 06/2016
2	Chronic Renal Insufficiency 01/2021 - 01/2017
2	Fibrosis (Cirrhosis) 01/2021 - 03/2014
2	Acidosis 12/2019 - 07/2016
2	Hypercalcemia (Milk Alkali Syndrome) 12/2019 - 07/2016
2	Polyuria 01/2017 - 03/2014
1	Atrophy 01/2021
1	Diabetes Insipidus 12/2019
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2017
1	Albuminuria 01/2017
1	Diabetes Mellitus 01/2017
1	Acute Kidney Injury (Acute Renal Failure) 01/2017
1	Body Weight (Weight, Body) 01/2017
1	Hyponatremia 07/2016
1	Hyperkalemia 07/2016
1	Chronic Kidney Failure (Chronic Renal Failure) 06/2016
1	Polydipsia 03/2014
1	Inflammation (Inflammations) 01/2008
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2008
1	Heart Failure 01/2007
1	Transfusion Reaction 02/2006
1	Myocardial Stunning (Stunned Myocardium) 01/2006

Drug/Important Bio-Agent (IBA)

10	LithiumIBA 01/2021 - 07/2007
2	Acetazolamide (Diamox)FDA LinkGeneric 01/2017 - 07/2016
1	Immunoglobulin G (IgG)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 01/2017
1	Glycogen Synthase Kinase 3IBA 01/2017
1	Vasopressins (Vasopressin)IBA 01/2017
1	Insulin (Novolin)FDA Link 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	ThiazidesIBA 07/2016
1	Amiloride (Midamor)FDA LinkGeneric 07/2016
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 03/2014
1	Sodium Chloride SymportersIBA 03/2014
1	EnzymesIBA 01/2008
1	Biomarkers (Surrogate Marker)IBA 01/2008
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2008
1	LactoferrinIBA 01/2008
1	Pharmaceutical PreparationsIBA 07/2007
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2007
1	pro-brain natriuretic peptide (1-76)IBA 01/2007
1	AntigensIBA 02/2006
1	AntibodiesIBA 02/2006
1	Troponin T (Troponin T1)IBA 01/2006

Therapy/Procedure

1	Therapeutics 06/2016